The double edge of the HSP90-CDC37 chaperone machinery: Opposing determinants of kinase stability and activity

Future Oncology

Volumn 8, Issue 8, 2012, Pages 939-942

  Xu, Wanping ^a   Neckers, Len ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CDC37; CHIP; HSP HSC70; HSP90; LKB1

Indexed keywords

CELL CYCLE PROTEIN 37; PROTEIN KINASE LKB1; UBIQUITIN PROTEIN LIGASE;

ARTICLE; AUTOPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; HALF LIFE TIME; PRIORITY JOURNAL;

EID: 84865213364     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.80     Document Type: Article

References (15)

1. Boudeau J, Deak M, Lawlor MA, Morrice NA, Alessi DR. Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 370(Pt 3), 849-857 (2003).
2. Nony P, Gaude H, Rossel M, Fournier L, Rouault JP, Billaud M. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37. Oncogene 22(57), 9165-9175 (2003).
3. Gaude H, Aznar N, Delay A et al. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Oncogene 31(12), 1582-1591 (2012).
4. Salminen A, Lehtonen M, Paimela T, Kaarniranta K. Celastrol: molecular targets of Thunder God Vine. Biochem. Biophys. Res. Commun. 394(3), 439-442 (2010).
5. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc. Natl Acad. Sci. USA 99(20), 12847-12852 (2002).
6. Towler MC, Fogarty S, Hawley SA et al. A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesis. Biochem. J. 416(1), 1-14 (2008).
7. Denison FC, Hiscock NJ, Carling D, Woods A. Characterization of an alternative splice variant of LKB1. J. Biol. Chem. 284(1), 67-76 (2009).
8. Sebbagh M, Olschwang S, Santoni MJ, Borg JP. The LKB1 complex-AMPK pathway: the tree that hides the forest. Fam. Cancer 10(3), 415-424 (2011).
9. Nolen B, Taylor S, Ghosh G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15(5), 661-675 (2004).
10. Zeqiraj E, Filippi BM, Deak M, Alessi DR, Van Aalten DM. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 326(5960), 1707-1711 (2009).
11. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell. Mol. Life Sci. 55(5), 735-750 (1999).
12. Donze O, Abbas-Terki T, Picard D. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 20(14), 3771-3780 (2001).
13. Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc. Natl Acad. Sci. USA 103(30), 11318-11322 (2006).
14. Xu W, Yuan X, Beebe K, Xiang Z, Neckers L. Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity. Mol. Cell. Biol. 27(1), 220-228 (2007).
15. Xu W, Mollapour M, Prodromou C et al. Dynamic tyrosine phosphorylation modulates cycling of the Hsp90-p50(Cdc37)-AHA1 chaperone machine. Mol. Cell doi:10.1016/j.molcel.2012.05.015 (2012) (Epub ahead of print).